Isentress and Atrioventricular block second degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block second degree is reported as a side effect among people who take Isentress (raltegravir potassium), especially for people who are male, 20-29 old, have been taking the drug for 5 - 10 years also take Truvada, and have Abdominal distension.

The phase IV clinical study analyzes which people have Atrioventricular block second degree when taking Isentress. It is created by eHealthMe based on reports of 16,310 people who have side effects when taking Isentress from the FDA, and is updated regularly.

What is Isentress?

Isentress has active ingredients of raltegravir potassium. It is often used in hiv infection. eHealthMe is studying from 16,529 Isentress users. Check the latest studies of Isentress.

What is Atrioventricular block second degree?

Atrioventricular block second degree (heart block second degree) is found to be associated with 377 drugs and 818 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.

On Jul, 15, 2026

16,310 people reported to have side effects when taking Isentress.
Among them, 19 people (0.12%) have Atrioventricular block second degree.

Could Isentress cause Atrioventricular block second degree?

Among these 19 people:

How long have people been on Isentress when they have Atrioventricular block second degree? *

What is the gender of people who have Atrioventricular block second degree when taking Isentress? *

female: 36.84 %
male: 63.16 %

What is the age of people who have Atrioventricular block second degree when taking Isentress? *

What are other drugs people take besides Isentress? *

What are other side effects people have besides Atrioventricular block second degree? *

Bradycardia (abnormally slow heart action): 12 people, 63.16%
Abdominal Distension: 11 people, 57.89%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 47.37%
Hepatic Function Abnormal: 9 people, 47.37%
Liver Function Test Abnormal: 9 people, 47.37%
High Blood Cholesterol: 9 people, 47.37%
Oropharyngeal Discomfort (pain or irritation of oropharynx): 7 people, 36.84%
Anaemia (lack of blood): 7 people, 36.84%
Tachycardia Paroxysmal (a form of tachycardia which begins and ends in an acute (or paroxysmal) manner): 7 people, 36.84%
Campylobacter Gastroenteritis (infection of gastrointestinal system): 7 people, 36.84%

What are the existing conditions these people have? *

Abdominal Distension: 8 people, 42.11%
Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 7 people, 36.84%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 7 people, 36.84%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 5 people, 26.32%
Urinary Tract Infection: 5 people, 26.32%
Anaemia (lack of blood): 5 people, 26.32%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 15.79%
Dyslipidaemia (abnormal amount of lipids): 3 people, 15.79%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.53%
High Blood Pressure: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Isentress and have Atrioventricular block second degree?

- Check whether Atrioventricular block second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isentress:

Isentress (16,529 reports)

Browse all side effects of Isentress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (377 drugs)

Browse all the conditions that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (818 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir potassium (the active ingredients of Isentress) and Isentress (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.